Patent ID: 6861045

Claim:
A method for monitoring treatment of a tissue comprising HSA in a patient, said method comprising: a) administering a contrast agent to said patient, wherein said contrast agent is selected from the group consisting of MS-315, MS-317, MS-322, MS-323, MS-325, MS-326, MS-327, and MS-328; b) subjecting said patient to magnetic resonance imaging to determine an initial signal intensity value in a region of interest of said undesired tissue; c) applying an interventional therapy to at least a portion of said undesired tissue in order to treat said undesired tissue, said interventional therapy selected from the group consisting of a thermal energy generation, a cryoablation, an injection of a denaturing liquid, an injection of a chemotherapeutic agent, and a photodynamic therapy; and d) contemporaneously monitoring with magnetic resonance imaging change in said initial signal intensity value in said region of interest of said undesired tissue during said interventional therapy.